Haemonetics Corp. (HAE)
105.30
-0.70
(-0.66%)
USD |
NYSE |
Sep 25, 16:00
105.40
+0.10
(+0.09%)
After-Hours: 19:59
Haemonetics Enterprise Value : 5.739B for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 5.739B |
| September 24, 2026 | 5.771B |
| September 23, 2026 | 5.808B |
| September 22, 2026 | 5.885B |
| September 21, 2026 | 5.895B |
| September 18, 2026 | 5.880B |
| September 17, 2026 | 5.843B |
| September 16, 2026 | 5.782B |
| September 15, 2026 | 5.780B |
| September 14, 2026 | 5.785B |
| September 11, 2026 | 5.620B |
| September 10, 2026 | 5.546B |
| September 09, 2026 | 5.642B |
| September 08, 2026 | 5.627B |
| September 04, 2026 | 5.631B |
| September 03, 2026 | 5.627B |
| September 02, 2026 | 5.631B |
| September 01, 2026 | 5.587B |
| August 31, 2026 | 5.638B |
| August 28, 2026 | 5.678B |
| August 27, 2026 | 5.725B |
| August 26, 2026 | 5.798B |
| August 25, 2026 | 5.876B |
| August 24, 2026 | 5.880B |
| August 21, 2026 | 5.898B |
| Date | Value |
|---|---|
| August 20, 2026 | 5.872B |
| August 19, 2026 | 5.880B |
| August 18, 2026 | 5.709B |
| August 17, 2026 | 5.055B |
| August 14, 2026 | 5.080B |
| August 13, 2026 | 5.060B |
| August 12, 2026 | 5.104B |
| August 11, 2026 | 4.917B |
| August 10, 2026 | 4.889B |
| August 07, 2026 | 4.945B |
| August 06, 2026 | 4.817B |
| August 05, 2026 | 4.752B |
| August 04, 2026 | 4.833B |
| August 03, 2026 | 4.897B |
| July 31, 2026 | 4.840B |
| July 30, 2026 | 4.808B |
| July 29, 2026 | 4.835B |
| July 28, 2026 | 4.704B |
| July 27, 2026 | 4.584B |
| July 24, 2026 | 4.533B |
| July 23, 2026 | 4.470B |
| July 22, 2026 | 4.499B |
| July 21, 2026 | 4.501B |
| July 20, 2026 | 4.505B |
| July 17, 2026 | 4.491B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.521B |
| Abbott Laboratories | 202.93B |
| AngioDynamics, Inc. | 603.03M |
| Alphatec Holdings, Inc. | 2.054B |
| AtriCure, Inc. | 2.876B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 33.01M |
| Revenue (Quarterly) | 339.38M |
| Total Expenses (Quarterly) | 306.37M |
| EPS Diluted (Quarterly) | 0.7223 |
| Gross Profit Margin (Quarterly) | 56.98% |
| Profit Margin (Quarterly) | 9.73% |
| Earnings Yield | 1.95% |
| Operating Earnings Yield | 5.06% |
| Normalized Earnings Yield | 3.174 |